Key result
Percutaneous transmyocardial laser revascularization using the Biosense DMR system improved angina scores more than the Eclipse system (1.2+/-1.1 vs. 2.3+/-0.9, P<0.05).
Why the study?
Does PTMR with Biosense DMR improve myocardial perfusion and LVF compared to Eclipse laser in patients not amenable to conventional revascularization?
Cohort (n=25)
Does PTMR with Biosense DMR improve myocardial perfusion and LVF compared to Eclipse laser in patients not amenable to conventional revascularization?
Absolute Event Rate: 1.2% vs 2.3%
p-value: p=<0.05
PTMR with Biosense DMR provides superior improvement in angina symptoms and myocardial electrical activity compared to the Eclipse laser system, though neither improved global LVF.
May favor DMR over Eclipse for angina relief in PTMR; leaves open effects on perfusion or LV function.
BACKGROUND AND OBJECTIVES: Myocardial perfusion and left ventricular function (LVF) were assessed after percutaneous transmyocardial laser revascularization (PTMR) in patients not amenable to conventional revascularization, with a comparison of two laser systems. STUDY DESIGN/MATERIALS AND METHODS: PTMR was performed with an Eclipse laser in 15 patients, and with a Biosense DMR in 10 patients. (201)Thallium scintigraphy, coronary angiography, and ventriculography were performed at baseline and at the 7.5+/-4.3-month follow-up. All patients in the Biosense DMR group and 10 in the Eclipse group underwent NOGA mapping before PTMR and after follow-up. RESULTS: The event-free survival rates were comparable, and the angina scores of all patients improved significantly, but more so in the Biosense DMR group than in the Eclipse group (1.2+/-1.1 vs. 2.3+/-0.9, P < 0.05). Both, the electrical activity assessed by NOGA mapping and the normalized (201)thallium uptake at redistribution improved significantly in the treated segments after Biosense DMR, while the global LVF decreased insignificantly in the Eclipse group. CONCLUSIONS: PTMR resulted in significant improvements in the clinical symptoms, but the electrical activity improved only in the Biosense DMR group, without transforming to a better LVF.
No takes yet. Share an insight, caveat, or question.
Strehblow et al. (2003) conducted a cohort in Patients not amenable to conventional revascularization (n=25). Biosense DMR laser system vs. Eclipse laser system was evaluated on Angina score (p=<0.05). Percutaneous transmyocardial laser revascularization using the Biosense DMR system improved angina scores more than the Eclipse system (1.2+/-1.1 vs. 2.3+/-0.9, P<0.05).
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: